UNSPSC 51292403: Bifemelane hydrochloride

This classification denotes the hydrochloride form of an antidepressive agent with the molecular formula C18H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z4501GN13G, chemically known as 1-butanamine, n-methyl-4-(2-(phenylmethyl)phenoxy)-, hydrochloride but more generally known as bifemelane, which bears US NIH Compound Identifier 2377. Bifemelane most often comes in base and hydrochloride forms.

UNSPSC 51292403 Bifemelane hydrochloride is a Commodity code, but the recent state and local procurement activity tagged under it diverges sharply from the code's pharmaceutical scope. The single opportunity in the recent record — Seminole County, Florida's IFB60459723LAS — solicits Naloxone and Safe Drug Deactivation Systems, neither of which falls within bifemelane hydrochloride's stated product line. The mismatch suggests either a coding error in the source data or opportunistic tagging that does not reflect actual procurement need under this code. No other recent state and local opportunities appear in the record for this Commodity code.

The Seminole County solicitation, posted June 30, 2026 with a response deadline of July 26, 2023, calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically, include all shipping and delivery costs in their pricing, provide unit costs for each line item, maintain workers' compensation and commercial general liability insurance, and comply with drug-free workplace certification and E-Verify requirements. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period allowing termination without cause. Potential FEMA funding introduces additional federal compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act. The source reports no explicit set-aside designations for disadvantaged enterprises.